NYSE:BDXMedical Equipment
Elyra Kidney Stone Laser Launch Tests Becton Dickinson Execution Story
Becton Dickinson (NYSE:BDX) has launched the Elyra Thulium Fiber Laser System for kidney stone procedures.
The new system expands BD’s urologic stone management portfolio and is now available in the United States.
The launch is aimed at supporting procedural efficiency and workflow for urology teams treating kidney stones.
Becton Dickinson, trading at around $146.25 per share, is adding the Elyra Thulium Fiber Laser System to its existing kidney stone care portfolio. For investors tracking...